K. Aldape

721 total citations
5 papers, 520 citations indexed

About

K. Aldape is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, K. Aldape has authored 5 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Genetics, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Oncology. Recurrent topics in K. Aldape's work include Glioma Diagnosis and Treatment (4 papers), Brain Metastases and Treatment (3 papers) and Cancer Treatment and Pharmacology (2 papers). K. Aldape is often cited by papers focused on Glioma Diagnosis and Treatment (4 papers), Brain Metastases and Treatment (3 papers) and Cancer Treatment and Pharmacology (2 papers). K. Aldape collaborates with scholars based in United States and Canada. K. Aldape's co-authors include Minesh P. Mehta, Mark R. Gilbert, Burt G. Feuerstein, Kruttika Bhat, Robert B. Jenkins, J. Gregory Cairncross, Steven N. Popoff, Christopher E. Pelloski, David N. Louis and Heidi Phillips and has published in prestigious journals such as Neuro-Oncology.

In The Last Decade

K. Aldape

5 papers receiving 512 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K. Aldape United States	3	368	224	188	132	92	5	520
Roxanne Marshall United States	5	265 0.7×	199 0.9×	152 0.8×	87 0.7×	87 0.9×	6	433
Joerg Felsberg Germany	12	247 0.7×	227 1.0×	166 0.9×	75 0.6×	80 0.9×	22	441
Kristin Diefes United States	7	326 0.9×	396 1.8×	214 1.1×	115 0.9×	83 0.9×	8	720
Adesh Tandon United States	4	320 0.9×	284 1.3×	221 1.2×	108 0.8×	81 0.9×	5	561
P. Y. Wen United States	5	324 0.9×	194 0.9×	138 0.7×	182 1.4×	95 1.0×	5	506
Christopher J. Pirozzi United States	12	255 0.7×	374 1.7×	246 1.3×	101 0.8×	105 1.1×	25	689
Michael Badruddoja United States	8	387 1.1×	238 1.1×	160 0.9×	167 1.3×	152 1.7×	20	681
Regina Sycheva Russia	13	383 1.0×	212 0.9×	144 0.8×	111 0.8×	106 1.2×	18	541
Marjut Puputti Finland	10	190 0.5×	269 1.2×	138 0.7×	138 1.0×	123 1.3×	11	494
H. Goike Sweden	8	281 0.8×	341 1.5×	150 0.8×	204 1.5×	189 2.1×	10	690

Countries citing papers authored by K. Aldape

Since Specialization

Citations

This map shows the geographic impact of K. Aldape's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Aldape with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Aldape more than expected).

Fields of papers citing papers by K. Aldape

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Aldape. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Aldape. The network helps show where K. Aldape may publish in the future.

Co-authorship network of co-authors of K. Aldape

This figure shows the co-authorship network connecting the top 25 collaborators of K. Aldape. A scholar is included among the top collaborators of K. Aldape based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Aldape. K. Aldape is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Armstrong, Terri S., Elizabeth Vera‐Bolanos, Ying Yuan, et al.. (2014). AT-07 * A PHASE II STUDY OF LAPATINIB AND DOSE-DENSE TEMOZOLOMIDE (TMZ) FOR ADULTS WITH RECURRENT EPENDYMOMA: PATIENT REPORTED OUTCOMES (PRO) FROM A CERN CLINICAL TRIAL. Neuro-Oncology. 16(suppl 5). v9–v9. 1 indexed citations

2.

Gilbert, Mark R., Ying Yuan, Khalida Wani, et al.. (2014). AT-23 * A PHASE II STUDY OF LAPATINIB AND DOSE-DENSE TEMOZOLOMIDE (TMZ) FOR ADULTS WITH RECURRENT EPENDYMOMA: A CERN CLINICAL TRIAL. Neuro-Oncology. 16(suppl 5). v13–v13. 12 indexed citations

3.

Singh, Sanjay K., et al.. (2014). TM-02 * IDENTIFICATION OF THE AZOLE CLASS OF ANTIFUNGALS AS POTENT INHIBITORS OF HEXOKINASE II MEDIATED TUMOUR METABOLISM IN GLIOBLASTOMA. Neuro-Oncology. 16(suppl 5). v213–v213. 1 indexed citations

4.

Raizer, Jeffery J., L. E. Abrey, Andrew B. Lassman, et al.. (2009). A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy. Neuro-Oncology. 12(1). 95–103. 221 indexed citations

5.

Colman, Howard, Lin Zhang, Erik P. Sulman, et al.. (2009). A multigene predictor of outcome in glioblastoma. Neuro-Oncology. 12(1). 49–57. 285 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact